WO2007042348(特表2009-511969)
"13. The composition of claim 1 wherein said composition has an extinction coefficient k（吸光係数k；＊不定冠詞）of 0.05 to 0.25 with respect to a radiation wavelength of 193nm."
WO03044077(特表2005-509710)
"Figure 4 shows for the inventive siloxane polymer family (absorbing at 193 nanometers) the concave/convex shaped relationship that exists between extinction coefficient k（吸光係数k；＊無冠詞）and the ratio of the starting silanes."
"Honeywell Accuglass @ 720 material comprises methylphenylsilsequioxane of the general formula (Ro 1. 0) (S'01. 5-2. 0),.,, and an incorporatable organic absorbing compound and has a k (at 193 nanometers) of 0.6 to 0.65 but has an inadequate etch rate. Our US Patent 6,268, 457B1 teaches an improved spin- on glass anti-reflective coating comprising at least organic dye useful for deep ultraviolet photolithography and teaches ten different useful dyes having at least two fused or unfused benzene rings. Subsequent to the work in our US Patent 6,268, 457B1 and prior to the present invention, we undertook an experiment wherein we varied the amount of dye and maintained constant all other amounts of starting materials. The resulting linear relationship between the amount of dye present and the extinction coefficient k（吸光係数k；＊定冠詞）is plotted in Figure 1."
"Analytical Test Methods:
Optical Properties and Thickness: Extinction coefficient (k)（吸光係数；＊無冠詞）was determined by using n & k Technology Inc.'s 1200 and 1 512 tool to measure the reflectance spectrum and then using n & k Technology Inc.'s software to calculate thickness, n, and k from the measured reflectance."
WO2015074004(特表2017-502310)
"A thin lossy film（損失性膜）may be made from any suitable material. For example, a thin lossy film may be made from a material where the index of refraction n is approximately the same order of magnitude as the extinction coefficient k（吸光係数k；＊定冠詞）for the material. In some embodiments, a thin lossy film may be made from a material where the index of refraction n is within about two orders of magnitude difference from the value of the extinction coefficient k of the material. Non-limiting examples of such materials at visible wavelengths are germanium and silicon."
US9177796(特表2016-525788)
"SiOxNy films, formed by Physical Vapor Deposition from a silicon target, have a refractive index n ranging between 1.5 to 2.5 and an extinction coefficient K（吸光係数k；＊不定冠詞）of around 0 to 0.3 at exposure wavelength 193 nm."
以上以下
WO2016044334(特表2017-528480)
"1. A stable aqueous pharmaceutical formulation, the formulation comprising a monoclonal antibody, trehalose, and a buffer, wherein the weight ratio of said monoclonal antibody to said trehalose in the formulation is greater than or equal to（以上）0.41 and less than（未満）1.65, wherein the formulation has a pH of about 5.5 to about 7.0, and wherein the monoclonal antibody binds VEGF."
WO2016007664(特表2017-525676)
"23. The nanoparticulate carrier formulation of claim 1 , wherein the nanoparticles have an average diameter in the range from about 10 nm to（の範囲）about 30 nm."
WO2015066444(特表2016-535777)
"8. The pharmaceutical composition of claim 1 , wherein the ratio of the weight of the loteprednol etabonate to the weight of the surface-altering agent present in the pharmaceutical composition is greater than or equal to（以上）about 1 : 1, and less than or equal to（以下）about 3: 1."
WO2016048765(特表2017-533293)
"5. The method of any previous Claim, the method further characterized by the nonionic surfactant and the anionic surfactant each independently being present at a concentration of 0.01 weight-percent or more（以上）and ten weight-percent or less（以下）based on total aqueous solution weight."
WO2014110012(特表2016-511647)
"3. The microfluidic device of claim 2, wherein the first substrate has a thickness of no less than（以上）50 microns and no greater than（以下）10 millimeters."
WO2014035679(特表2015-535389)
"10. The method according to claim 1 , wherein the activating step occurs using microwave at a frequency greater than or equal to（以上）about 1.5 Ghz and less than or equal to（以下）about 8.5 GHz."
WO2014014798(特表2015-527970)
"12. The glass article of claim 11, wherein a ratio of Fe203 (mol.%) to Ti02(mol.%) is greater than or equal to（以上）about 0.52 and less than or equal to（以下）about 1.22.”
WO2013059293(特表2014-530367)
"6. A method according to any of claims 4 or 5, wherein said second solid support is chosen from the group consisting of microparticles（微粒子）, magnetic microparticles, beads, and microchannels."
WO2009137275(特表2011-523041)
(Ab)
"The current invention provides compositions, which are useful as stationary phases for a variety of chromatographic applications, such as high performance liquid chromatography (HPLC) and solid-phase extraction (SPE). The compositions include a porous solid support (e.g., silica gels, silica monoliths or synthetic organic resins) having an exterior surface and pore openings defined by "interior walls". To the solid support are covalently bound organic ion-exchange ligands (e.g., silyl ligands), which incorporate at least one ion-exchange group (e.g., ionic or ionizable group). The compositions further include micro-particles（微粒子）(e.g., latex particles) incorporating ion-exchange groups having a charge that is opposite to the charge found on the support"
WO2016069762(特表2017-534056)
"For purposes of capture, the antigens and/or antibodies of which the immunodiagnostic reagent is comprised can be coated on a solid support such as for example, a microparticle（微粒子）, (e.g., magnetic particle), bead, test tube, microtiter plate, cuvette, membrane, scaffolding molecule, film, filter paper, disc or chip. In this regard, where the immunodiagnostic reagent comprises a combination of antigens (e.g., directed at different HCV proteins or different fragments of the same HCV protein), the antigens can be co-coated on the same solid support or can be on separate solid supports."
WO2008063838(特表2010-508044)
"Alternatively, these compounds may be attached to other substrate such as microparticles（微粒子）, magnetic beads, or solid substrates. When incubated with a sample, potential non-target bacteria will selectively bind to the substrate. The substrate then can be physically removed from the sample. Separation methods include centhfugation of microparticles, application of a magnetic field for isolating magnetic beads, or other separation process."
WO2016061230(特表2017-531296)
"11. The enhanced breakdown strength dielectric material of claim 2, wherein the filler material comprises one or more particulates（微粒子）, each having a shape selected from spheres, plates, platelets, cubes, needles, oblate, spheroids, pyramids, prisms, flakes, rods, fibers, chips, whiskers, and mixtures thereof."
WO2009108275(特表2011-514933)
(Ab)
"Particulate generation has been a problem in semiconductor device processing in highly corrosive plasma environments. The problem is exacerbated（深刻；＊悪化）when the plasma is a reducing plasma（還元プラズマ）. Empirically produced data has shown that the formation of a plasma spray coated（プラズマ溶射被覆）yttrium-comprising ceramic such as yttrium oxide, Y2O3 - ZrO2 solid solution, YAG, and YF3 provides a low porosity coating with smooth and compacted（緻密）surfaces when such ceramics are spray coated from a powder feed having an average effective diameter ranging from about 22µm to about 0.1 µm. These spray- coated materials reduce the generation of particulates（微粒子）in corrosive reducing plasma environments."
WO2014064400(特表2016-500907)
"From an API source perspective, the combination of a close-coupled impactor（密結合インパクター）which also serves as a charged ionization surface provides the basis of a sensitive multimode ionization source. The spray tip（スプレーチップ）and micro target are preferably configured in close proximity with a glancing impact geometry which results in increased spray flux（噴霧束）at the target and significantly less beam divergence or reflected dispersion when compared to a known broad area SACI ion source."
"According to an embodiment the inner diameter of the liquid capillary tube 3 is 130 μηη and the outer diameter of the liquid capillary tube 3 is 270 μηη. The inner diameter of the second (gas) capillary tube 4 is preferably 330 μηη. This arrangement produces a nebulised spray（噴霧スプレー）which contains droplets with a typical diameter of 10-20 μηη and which have velocities greater than 100 m/s at a close distance from the sprayer tip（スプレーヤーチップ）."
"According to the preferred embodiment the mesh wire size and spacing is preferably sized appropriately so as to provide several discrete impact zones within the impact zone or area. The wire diameter is preferably sufficient so as to allow the impact of the plume on the wire to improve nebulisation（噴霧）."
WO2012100120(特表2014-515861)
"2. The system according to claim 1, wherein the probe comprises a spray emitter（スプレー放射体）and a high voltage source, wherein the probe is configured such that the high voltage source is not in contact with spray（スプレー）emitted by the spray emitter."
WO2011163632(特表2013-534826)
"Selection of ΤΠ Transformed Plants: T\seed was sown on 10.5" x 21" germination trays (T.O. Plastics Inc., Clearwater, MN) as described above and grown under the conditions outlined. The domes were removed 5-6 days post-sowing. 5 days post-sowing, and again 10 days post-sowing, seedlings（苗）were sprayed with（噴霧）a 0.20% solution of glufosinate herbicide (Liberty) in a spray volume（噴霧量）of 10 mL/tray (703 L/ha) using a DeVilbiss compressed air spray tip（スプレーチップ）to deliver an effective rate of 280 g/ha glufosinate per application. 10 mL of the glufosinate herbicide solution was pipetted into（分注）a 20 mL scintillation vial for each tray to be sprayed. The spray was delivered using a horizontal and vertical application pattern. After each spray（スプレー）, a spray label with the herbicide name, application rate, and application date was added to each selection tray. 4 to 7 days after the second spray, herbicide-resistant plants were identified and transplanted into pots prepared with Sunshine mix LP5. Transplanted plants were placed in a greenhouse with the above mentioned growth conditions. Six to eight weeks after transplanting, the seed from each plant was harvested and stored separately with a unique identification number."
WO2016081475(特表2018-501201)
"FIGURE 7 shows particle size distribution of micronized（微粒子化）/lactose blend combination, which is determined by Next Generation Impactor (NGI)"
"According to some other embodiments, the dry powder is produced by micronization（微粒子化）"
"The term "nebulizer（ネブライザー）" as used herein refers to a device used to administer liquid medication in the form of a mist（霧）inhaled into the lungs."
WO2016061611(特表2017-532581)
"Clotting agents or coagulants are classified as either intrinsic clotting agents or extrinsic clotting agents according to the blood cascade stimulated (see for example US patent no. 6,686,204). Suitable clotting agents include, but are not limited to, diatomaceous earth, microparticles or particles of inorganic silicates, microsilica, glass microparticles, ellagic acid, thrombin, heparinase, thromboplastin, batroxobin, hydroyapitite, kaolin, kaolin particles, prothrombin (including microparticulated（微粒子化された）prothrombin), fibrinogen, and depolymerised collagen."
WO2016025911(特表2017-524743)
"16. The method according to claim 15, wherein the bioactive agent, prior to step (b), is micronized（微粒子化）by a process selected from the group consisting of solvent evaporation, hot melt particle formation, solvent removal, spray drying, phase inversion, coacervation, low temperature casting, and film casting."
WO2016014586(特表2017-521181)
"Prior art dry powder inhalers (DPIs) usually have a means for introducing the drug (active drug plus carrier) into a high velocity air stream. The high velocity air-stream is used as the primary mechanism for breaking up the cluster of micronized（微粒子化）particles or separating the drug particles from the carrier. Several inhalation devices useful for dispensing this powder form of medication are known in the prior art."
WO2012052459(特表2013-544794)
"Generally, pharmaceutical compositions suitable for intranasal or inhaled administration may conveniently be formulated as aerosols, solutions, suspensions, drops, gels or dry powders, with one or more pharmaceutically acceptable（薬学的に許容される）carriers and/or excipients such as aqueous or non-aqueous vehicles, thickening agents, isotonicity adjusting agents, antioxidants and/or preservatives. For compositions suitable for intranasal or inhaled administration, the compound of formula (I) or a prodrug thereof, or a pharmaceutically acceptable salt thereof, may typically be in a particle-size-reduced form, which may be prepared by conventional techniques, for example, micronisation（微粒子化）and milling（粉砕）. Generally, the size-reduced (e.g. micronised（微粒子化）) compound of formula (I) or a prodrug thereof, or a pharmaceutically acceptable salt thereof, can be defined by a D50 value of about 0.5 to 10 microns, such as of about 2 to 4 microns (for example as measured using laser diffraction)."
"An example of a cosolvent includes, but is not limited to ethanol. Aerosol compositions may be presented in single or multidose quantities in sterile form in a sealed container, which may take the form of a cartridge or refill for use with an atomising device（霧化装置）or inhaler. Alternatively, the sealed container may be a unitary dispensing device such as a single dose nasal inhaler or an aerosol dispenser fitted with（取り付けられた）a metering valve (metered dose inhaler), which is intended for disposal once the contents of the container have been exhausted."
WO2010124210(特表2012-524909)
"5. The method of any one of claims 1-4, wherein the inkwell has inter-well spacings, well dimensions, or both, which correspond to tip apex spacings（チップ先端間隔）, tip dimensions, or both, of the tips of the tip array, respectively."
WO2009132331(特表2011-518621)
"1. A device for delivery of a fluid to a surgical site（手術部位）comprising: an applicator comprising at least one fluid delivery lumen（流体送達管腔）, said applicator having a proximal end（基端）and a distal end（先端）; and an applicator tip having a proximal end and a distal end, said applicator tip proximal end（チップ先端）comprising at least one fluid delivery lumen or semi-permeable material capable of fluidly connecting to the at least one fluid delivery lumen of said applicator, and said applicator tip distal end comprising the at least one fluid-permeable material or an opening; wherein the applicator dista! end and the applicator tip proximal end are configured to detachably couple to each other."
WO2006032879(特表2008-513535)
"The solution was then heated to 60<0>C. Sodium chloride (NaCI, MW 57.96, 200 g, 3.45 mol) was slowly added to the (hot) solution. (Caution must be exercised（注意を払う必要）because residual DCM may cause the solution to bump（突沸）.) Slow cooling (in excess of 3.5 hours) caused methylthioninium chloride (MTC) to precipitate in a highly crystalline form. The precipitate was collected by vacuum filtration and dried in an oven at 60[deg.]C."
WO2010059658(特表2012-509335)
"The resulting mixture was filtered through 0.45μM filter disk and injected into a Varian RPHPLC (CH3CN/H2O w/0.1 %TFA). The fraction containing the desired product were combined and concentrated (material bumped（突沸した）on rotary evaporator and a significant amount of material was lost) to afford a TFA salt of the title compound as a yellow solid (21 mg)."
WO2012033648(特表2013-539855)
"1. A method of determining a permeation rate（透過率）permeation of a substance through a material; said substance impacting（衝突させ）said material on a first surface and said measurement being a rate of movement of said substance through said material due to permeation of said substance through said material, said method comprising:
placing a sampling of said substance from said second surface of said material in an optical cavity; and
measuring a decay time（減衰時間）of certain energy applied to said cavity against a known time of decay of said energy in an absence of（存在しない場合における）said second surface substance."
WO2013122718(特表2015-509612)
"12. The method according to claim 1 1 , wherein the second source of actinic radiation（化学線源）is attenuated（減衰）by a method selected from the group consisting of positioning a shutter between the second source of actinic radiation and the backing layer, by positioning a filter between the second source of actinic radiation and the backing layer, by use of a second source of actinic- radiation that emits at a less efficient UV wavelength, by use of（用いること）a backing layer that absorbs a portion of the actinic radiation emitted by the second source of actinic radiation and combinations of one or more of the foregoing（これら；＊上記）."
WO2011127400(特表2013-527979)
"An apparatus that enables analysis of high power laser beams, comprising: an attenuating multispot module that includes a pair of high reflecting mirror plates disposed in parallel, spaced apart relation to one another at a common angle of incidence to a laser beam; said pair including a first mirror having an anti-reflection coating on a first surface thereof that faces（と対向する）a source of said laser beam and a highly reflective coating on a second surface thereof that faces away from（から離れる方向を向く）said source; said pair including a second mirror having an anti-reflection coating on a second surface thereof that faces away from said source and a highly reflective coating on a first surface thereof that faces said source; a first beam dump positioned out of a path of travel of（進行経路から外れたところ）said laser beam and in receiving relation to light（受光するように位置決めされる）reflected by said first and second mirrors; and a first camera for detecting spots of light that pass through said first and second mirrors; whereby said laser beam is substantially attenuated（減衰）so that it can be analyzed by said first camera."
WO2011028698(特表2013-503634)
"28. A method for detecting the activity of a protease associated with a cancerous or precancerous cell in a mammal, said method comprising:
(a) contacting a fluid sample from the mammal with（接触させる）a diagnostic assay, said assay comprising the nanoplatform assembly of any one of claims 1-22;
(b) exposing said assay to an energy source; and
(c) detecting a change in the optical extinction（光減衰）of said assay, wherein said change corresponds to said protease activity."
WO2007009042(特表2009-500872)
"22. The method as set forth in claim 21, wherein the detaching comprises:
applying a laser beam to the deposition substrate to the deposition substrate, the laser beam passing through the deposition substrate substantially unattenuated（減衰せずに）and being absorbed proximate to（近くで）the first principal surface of the stack of semiconductor layers."
WO201207314(特表2014-500406)
"12. The method of any of claims 1 to 4 or 6 to 11, where step A) is performed by dropping, spraying, or pouring the acyloxysilane or the solution onto（上に滴下）one or more surfaces of the substrate, by passing the substrate through a contained amount of the acyloxysilane or the solution; or by dipping the substrate in the acyloxysilane or the solution."
WO2012027238(特表2013-536302)
"1. A protective coating composition comprising:
an acrylic resin;
a reactive polyorganosiloxane or precursor therefor;
hexamethyldisiloxane; and
a solvent system;
wherein a drop of water dripped onto（滴下）a panel in accordance with the Water Release Test, the panel having been coated with the protective coating composition, will run off the panel in 10 seconds or less."
WO2007002598(特表2008-543510)
"2. The applicator according to claim 1, wherein the fluid drips on（上に滴下）a portion of the transducer tip that is proximal to the distal-most portion of the tip of the ultrasound wound therapy device."
WO0149112(特表2004-508004)
"1. A method for the vitrification of biological materials, said method comprising the steps of :
(a) suspending the biological material in a cryoprotective equilibration medium,
having a concentration of cryoprotectant (s) below that sufficient to protect against
ice formation to the glass transition temperature of the cryoprotective equilibration
medium ;
(b) rinsing the equilibrated biological material with a vitrification solution, the
vitrification medium having a concentration of cryoprotectant (s) sufficient to
protect against ice formation to the glass transition temperature of the vitrification
medium ; and
(c) dropping the vitrification solution-rinsed biological material in microdroplets
of vitrification solution onto（上に滴下）a solid surface with good heat conductivity having
been previously cooled down to about-150 C to about-180 C."
WO2011038114(特表2013-510559)
"12. A method for engineering an enzyme for use in detection of a substance of interest（目的物質）, said method comprising:
creating a mutation at a residue that participates in the catalytic function of the enzyme for a chosen substrate to reduce or abolish the catalytic activity of the enzyme for that substrate, wherein the catalytic activity of the mutant enzyme for that substrate can be restored by the substance of interest; and
creating another mutation in the enzyme, wherein the other mutation increases the catalytic activity and specificity of the mutant enzyme for a pre-selected substrate in the presence of（存在下で）the substance of interest."
WO0185952(特表2004-514409)
"36. A method for identifying an agent of interest（目的物質）that inhibits the activity of a protein multimer comprising modified IMPDH polypeptides, the method comprising: a) contacting the protein multimer with（接触させる）inosine-5'-monophosphate, nicotinamide adenine dinucleotide, and the agent of interest ; and b) detecting the level of the reduced form of inosine-5'-monophosphate or nicotinamide adenine dinucleotide which is generated, whereby a low level of the reduced form of inosine-5'-monophosphate or nicotinamide adenine dinucleotide generated indicates that the agent of interest inhibits IMPDH activity."
WO2015200657(特表2017-528537)
"The crude heptafluorobutyl methacrylate was added to a 3 liter flask fitted with a distillation head and a thermocouple. More inhibitor (3 grams of phenothiazine and 0.7 gram of MEHQ) were added to the distillation pot. The acrylate was distilled to give 156 of precut distilling at 142 mm Hg at a head temperature of 80 °C-86 °C (88% desired methacrylate). The desired material（目的物質）distilled at 86 °C-°C at 131 mm Hg; a total of 1934 grams of heptafluorobutyl methacrylate were obtained."
WO2014113571(特表2016-503663)
"As used herein, the term fermentation broadly refers to the conversion of organic materials into target substances（目的物質）by host cells, for example, the conversion of a carbon source by recombinant host cells into fatty acids or derivatives thereof by propagating a culture of the recombinant host cells in a media comprising the carbon source."
WO2016007968(特表2017-521664)
"1. A method for measuring the level of the tumor necrosis factor receptor superfamily member 8 protein (CD30) in a biological sample（生体試料）, comprising detecting and/or quantifying（定量化）the amount of one or more modified or unmodified CD30 fragment peptides in a protein digest prepared from said biological sample using mass spectrometry; and calculating the level of modified or unmodified CD30 protein in said sample; and
wherein said level is a relative level or an absolute level.
2. The method of claim 1, further comprising the step of fractionating（分画する）said protein digest prior to detecting and/or quantifying the amount of one or more modified or unmodified CD30 fragment peptides."
WO2014099312(特表2016-503884)
"1. A method for characterizing a hydrocarbon sample（炭化水素試料）, comprising:
obtaining a hydrocarbon sample comprising at least about 90 wt%（重量％）of saturate compounds;
forming aturate-ion adducts by laser desorption ionization in the presence of a soft Lewis acid;
detecting the saturate-ion adducts using mass spectrometry with a resolving power（分解能）of at least about 10,000, the detected saturate-ion adducts comprising a mass spectrum which is a list of accurate masses and intensities of the corresponding masses; selecting the detected saturate-ion adducts based on Kendrick mass defect values so that Kendrick mass defect values of between about 0.150 to about 0.400 are retained; assigning molecular formula to the selected saturate-ion adducts in the mass spectrum; and
determining weight percentages for compounds in the petroleum or hydrocarbon sample based on the intensities of the saturate-ion adducts."
WO2014064400(特表2016-500907）
"65. A method of ionising a sample（試料）comprising:
causing a stream predominantly（主に）of droplets to impact upon（衝突）one or more mesh or grid targets to ionise said droplets to form a plurality of analyte ions."
WO2013078222(特表2015-501932)
(Ab)
"In one aspect, the present invention provides methods of determining by mass spectrometry the amount in a sample（試料）of one or more kisspeptin-54-derived peptides selected from the group consisting of kisspeptin-54, kisspeptin-53, kisspeptin-52, kisspeptin-54(R14P), kisspeptin-53(R14P), and kisspeptin-52(R14P). These methods include subjecting the sample to（供する）ionization under conditions suitable to produce one or more multiply charged kisspeptin-54-derived peptide ions（多価イオン）detectable by mass spectrometry; determining by mass spectrometry the amount of one or more ions from each of the one or more kisspeptin-54-derived peptides; and using the amount of the determined ions to determine the amounts of the corresponding one or more kisspeptin-54-derived peptides in the sample."
WO2012012725(特表2013-541323)
"22. The method of any one of the claims 1 -6, wherein the >2n phagocytic cells and the =2n phagocytic cells are isolated from a bodily fluid sample（体液試料）, tissues, or cells of the subject（対象）."
What is difference between 'sample' and 'specimen'?
Sample: representative; statisctics, can be numbers
Specimen: individual; biology, requires physical representation
WO2015134827(特表2017-514003)
"13. The unit dose composition of any preceding claim, wherein said unit dose composition comprises at least two compartments, preferably wherein at least one compartment is superposed on（上に重ねて配置）another compartment."
WO2015103370(特表2017-502510)
"5. The nanoimprint lithography system of claim 1 wherein the template chuck is rotatable about an axis parallel to the retained template and normal to the central axis, thereby allowing the template chuck and the template retained thereon to tilt relative to a substrate disposed in superimposition with（と重ねて配置）the template chuck and retained template."
WO2015035425(特表2016-532276)
"10. The composite light source of any of claims 1-9 further comprising a neodymium filter placed over（に重ねて配置）the at least one blue light source, the at least one green or yellow-green light source, and the at least one red light source, such that most or all of the light emitted by the composite light source passes through the filter."
WO2013048488(特表2014-531686)
"3. The computer- implemented method of claim 1, wherein sensing further includes receiving a message relating to the use of the side sensor from the one or more intersecting points of the plurality of intersecting points, wherein the plurality of intersecting points are generated by placing first conductive lines provided in the touch panel over（に重ねて配置）second conductive lines provided in the flap."
WO2015026551(特表2016-534629)
"1. A method of securing（セキュアにする）content to be delivered via a communications network, comprising:
coding（コード化）a plurality of packets using a determined code to generate a coded set of packets; and
hashing a plurality of packets of the coded set of packets to generate a plurality of hashes.
2. The method of claim 1, further comprising:
combining the plurality of hashes into at least one packet; and at least one of:
signing（署名する）the at least one packet with an electronic signature（電子署名で）, and encrypting the at least one packet."
WO2013029048(特表2014-528198)
(Ab)
"Techniques for signer-initiated electronic document signing（署名する）via an electronic signature service using a mobile or other client device are described. Example embodiments provide an electronic signature（電子署名）service ("ESS") configured to facilitate the creation, storage, and management of documents and corresponding electronic signatures. In some embodiments, when a signer user receives an electronic signature document on a mobile device, the signer（署名者）may use a client module executing on（上で実行する）the mobile device to import the document into the ESS. Once the document is imported into the ESS, the signer can access, review, and sign the document at the ESS via the mobile device. After signing the document, the signer can use the mobile device to cause the ESS to provide the signed document to one or more recipients."
WO2016081147(特表2018-502483)
"1. A method for wireless communications at a user equipment (UE), comprising:
receiving a message during a first symbol period according to a first timing configuration;
decoding the message during a decoding time period that is shorter than the first symbol period; and
transmitting a response to the received message based at least in part on the decoding, the response transmitted during a second symbol period according to a second timing configuration, wherein the second timing configuration is staggered relative to（ずらして配置）the first timing configuration according to a predetermined offset."
WO2015179306(特表2017-517889)
"3. The heatsink of claim 2, wherein the first array has rows that are staggered from（ずらして配置）rows in the second array, and wherein the first array has columns that are staggered from columns in the second array."
WO2014046687(特表2015-529557)
"5. A microfluidic mixing device as in claim 3, further comprising an axis-asymmetric mixing actuator on an opposite side of the channel and staggered（ずらして配置）along the channel length with respect to the two axis-asymmetric mixing actuators located on a first side of the channel."
WO2013085819(特表2015-501051)
"7. The computing device of claim 1, wherein the one or more processors comprise two or more processors coupled to the circuit board assembly, wherein at least two of the processors are staggered across the width of（の幅にずらして配置）the computing device, wherein at least two rows of DIMMs are staggered across the width of the computing device in a complementary fashion to the staggered processors."
WO2012096725(特表2014-502782)
"10. The headlamp of claim 9 wherein the arc discharge light source is purposefully offset from（意図的にずらして配置）the first focal point of the substantially ellipsoidal reflector."
WO2007126510(特表2009-531709)
"4. The method of claim 3, wherein (C) further comprises obtaining a voltage drop across（による電圧降下）the path resistance associated with the selected sensor element, and determining the path resistance associated with the selected sensor element further based on the voltage drop across the path resistance associated with the selected sensor element."
WO2006127855(特表2008-543178)
"11. The method of Claim 8 or 9, including operating a first current mirror including a first diode-connected transistor and a first current mirror output transistor to reduce variation in the amplified common mode signal by limiting a voltage drop across（による電圧降下）a first degeneration resistor coupled to a first electrode of a first active load transistor in the controlled active load circuit by turning on the first diode-connected transistor in response to an overvoltage across the first degeneration resistor, the first active load transistor having a control electrode coupled to the control input of the controlled active load circuit, the method including producing a mirrored current in the first current mirror output transistor in response to a current in the first diode-connected transistor resulting from the overvoltage and conducting the mirrored current into a conductor coupled to the control input of the controlled active load circuit."
WO2015047542(特表2016-532085)
"[0018] In one specific configuration, the voltage supplied to comparator 214 by power supply 192 is 5 volts. Depending upon the value of pull up resistor 182, a voltage drop will occur across（による電圧降下が発生）transistor 190 when transistor is "on" during a pulse. Preferably, this voltage drop is less than about 100 mV. The combination of the pull up resistance 182 and the voltage 184 determine how much current flows through the transistor 190 when the transistor 190 is on. These components also determine how quickly any capacitance in the cabling of loop 160 is overcome（容量の影響が解消）, and thus how much charge（電荷）is capable of reaching the output circuitry 158 to replenish the power supply voltage before the next "on" cycle of transistor 190. A value of the pull up resistance 182 which is too high, too much cable capacitance, or a power supply 184 which has a voltage which is too low can limit the functionality of circuitry 158."
WO2009094134(特表2011-510609)
"Some such ICs may have feedback inputs, FI, for feeding back a voltage drop over（による電圧降下）a sense resistor, Rs, e.g., as shown in Figures 7 - 8, to regulate the switching circuit 24. The switching circuit 24 can use such a fedback voltage to adjust its duty value in a manner that stabilizes the current in the output driver circuit 12 to a preselected value as described below. Some such ICs may also have a control input (CI) to apply a DC bias voltage to regulate the duty value, D, of the switching circuit 24. The duty value, D, of the switching circuit 24 approximately defines the relation between the DC output voltage, Vo, of the DC-to-DC voltage converter and its DC source voltage, Vs, at steady state operation."
WO2012050610(特表2014-502131)
"[0038] With respect to the brake light fault detection, the brake switch 80 and the PTCs 90 and 92 are electrically connected to resistors 104 and 106. A microcontroller 108 (for example, a processor, integrated circuit, or the like) having a comparator, for example, is electrically connected between the resistors 104 and 106. Resistors 104 and 106 form a voltage divider（電圧分配器）of input voltage to the PTCs 90 and 92, as do resistors 110 and 112. The voltage drop across（による電圧降下）the PTCs 90 and 92 is used as inputs to a comparator within the microcontroller 108. If the voltage threshold is exceeded, transistor 118 is turned on, as discussed below. Note, the transistor 124 is used in conjunction with（連携して）Zener diode 126 as the power supply for the microcontroller 108."
